Gene Delivery Technologies Market Size, Share, Trends, & Industry Analysis Report By Mode (Biological, Chemical, Physical), By Method, By Application, By End User, and By Region – Market Forecast, 2025–2034

The gene delivery technologies market size is expected to reach USD 15.50 Billion by 2034, according to a new study by Polaris Market Research. The report “Gene Delivery Technologies Market Share, Size, Trends, Industry Analysis Report: By Mode, By Method, By Application, By End User, and By Region; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The gene delivery technologies market offers solutions for targeted gene therapy, genetic disorder treatment, and personalized medicine, including viral vectors, non-viral vectors, and CRISPR-based delivery systems for efficient gene transfer, precision targeting, and therapeutic efficacy.

Request a free sample copy or read the full market insights : gene delivery technologies market report

Market growth is driven by rising prevalence of genetic disorders and chronic diseases. In addition, increasing adoption of advanced delivery platforms in oncology, rare diseases, and personalized medicine is enhancing treatment effectiveness and patient outcomes.

Gene Delivery Technologies Market Report Highlights

Based on mode, biological dominated in 2024 due to high efficiency and widespread use in clinical gene therapy applications.

In terms of method, ex vivo delivery dominated in 2024 driven by effectiveness in modifying patient-derived cells prior to transplantation.

Based on application, the oncology segment projected to grow at fastest CAGR owing to increasing clinical trials and rising demand for targeted cancer therapies.

In terms of end user, academic and research institutes dominated in 2024 due to extensive use in laboratory and experimental studies.

North America dominated the global market in 2024, fueled by strong biotechnology infrastructure and high R&D investment.

Asia Pacific is projected to record the fastest growth, driven by rising patient population, expanding biotech investments, and increasing awareness of gene therapies.

Key players in the global market include Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Revvity, Inc., QIAGEN N.V., GenScript Biotech Corp., Takara Bio USA, Inc., Promega Corporation, Bio-Techne Corporation, Lonza Group AG, Oxford Biomedica PLC, Sartorius AG, and MaxCyte, Inc.

Polaris Market Research has segmented the market report based on mode, method, application, end user, and region:

By Mode (Revenue, USD Billion, 2020–2034)

Biological

Adenovirus

Retrovirus

AAV

Lentivirus

Other Viruses

Non-viral

Chemical

Physical

By Method (Revenue, USD Billion, 2020–2034)

Ex vivo

In vivo

In vitro

By Application (Revenue, USD Billion, 2020–2034)

Infectious Diseases

Oncology

Ophthalmology

Urology

Diabetes

CNS

Others

By End User (Revenue, USD Billion, 2020–2034)

Academic & Research Institutes

Pharmaceutical & Biotechnology Companies

Other End Users

By Region (Revenue, USD Billion, 2020–2034)

North America

The U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Netherland

Russia

Rest of Europe

Asia Pacific

China

India

Japan

Malaysia

South Korea

Indonesia

Australia

Rest of Asia Pacific

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Latin America

Saudi Arabia

UAE

South Africa

Israel

Rest of South Africa Show more